How I treat stage II colon cancer patients - ESMO Open
Colorectal Cancer - Physiopedia
All About Rectal Cancer | OncoLink
Colorectal cancer - The Lancet
Neuroblastoma Treatment (PDQ®) - PDQ Cancer Information Summaries - NCBI Bookshelf
Colorectal Cancer - Physiopedia
Pan-Asian adapted ESMO consensus guidelines for the management of patients with metastatic colorectal cancer: a JSMO–ESMO initiative endorsed by CSCO, KACO, MOS, SSO and TOS - Annals of Oncology
Frontiers | Targeting KRAS Mutant in Non-Small Cell Lung Cancer: Novel Insights Into Therapeutic Strategies
Bile Duct Cancer (Cholangiocarcinoma) Treatment - PDQ Cancer Information Summaries - NCBI Bookshelf
The most reliable surface marker for the identification of colorectal cancer stem‐like cells: A systematic review and meta‐analysis - Abbasian - 2019 - Journal of Cellular Physiology - Wiley Online Library
Frontiers | Molecular Network of Colorectal Cancer and Current Therapeutic Options
Colorectal cancer - The Lancet
Frontiers | The Versatile Roles of Cancer-Associated Fibroblasts in Colorectal Cancer and Therapeutic Implications
Diagnostic value of tumor markers in identifying favorable or unfavorable subsets in patients with cancer of unknown primary: a retrospective study | BMC Cancer | Full Text
Inflammatory fibroblasts mediate resistance to neoadjuvant therapy in rectal cancer - ScienceDirect
Advances in Colorectal Cancer Research | National Institutes of Health (NIH)
Endoscopic Removal of Colorectal Lesions—Recommendations by the US Multi-Society Task Force on Colorectal Cancer - Gastroenterology
Frontiers | Colorectal Cancer Stem Cells in the Progression to Liver Metastasis
Frontiers | Perspectives on Immunotherapy of Metastatic Colorectal Cancer
Gastrointestinal Complications (PDQ®) - PDQ Cancer Information Summaries - NCBI Bookshelf
Integrating circulating-free DNA (cfDNA) analysis into clinical practice: opportunities and challenges | British Journal of Cancer
Proteogenomic Analysis of Human Colon Cancer Reveals New Therapeutic Opportunities - ScienceDirect
Overview of serum and tissue markers in colorectal cancer: a primer for radiologists | SpringerLink
Gastrointestinal Complications (PDQ®) - PDQ Cancer Information Summaries - NCBI Bookshelf
Frontiers | Biomarkers in Colorectal Cancer: The Role of Translational Proteomics Research
Bile Duct Cancer (Cholangiocarcinoma) Treatment - PDQ Cancer Information Summaries - NCBI Bookshelf
CDX2 inhibits epithelial–mesenchymal transition in colorectal cancer by modulation of Snail expression and β-catenin stabilisation via transactivation of PTEN expression | British Journal of Cancer
